Zachary Fitch
Overview
Explore the profile of Zachary Fitch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
34
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bashian E, Bashian E, Kwon Y, Ambrosio M, Fitch Z, Taylor L, et al.
Transplant Proc
. 2025 Mar;
PMID: 40087049
Background: The development of effective direct-acting antiviral treatment (DAAT) for hepatitis C virus (HCV) has opened the possibility of using HCV+ donors. We aimed to assess the long-term feasibility of...
2.
Kwon Y, Burmistrova M, Zhu D, Lai A, Park A, Sharma A, et al.
J Thorac Cardiovasc Surg
. 2024 Dec;
PMID: 39725344
Background: In the setting of the obesity epidemic and donor organ shortage in the United States, there is a growing need to expand the donor organ eligibility criteria for orthotopic...
3.
Goldberger M, Mamoun N, Fitch Z, Bonadonna D, Schroder J, Welsby I
J Cardiothorac Vasc Anesth
. 2024 Dec;
39(2):494-496.
PMID: 39721921
No abstract available.
4.
Schmitz R, Manook M, Fitch Z, Anwar I, DeLaura I, Olaso D, et al.
Front Transplant
. 2024 Jul;
2:1230393.
PMID: 38993898
Introduction: One-third of HLA-incompatible kidney transplant recipients experience antibody mediated rejection (AMR) with limited treatment options. This study describes a novel treatment strategy for AMR consisting of proteasome inhibition and...
5.
Gao Q, Davis R, Fitch Z, Mulvihill M, Ezekian B, Schroder P, et al.
Xenotransplantation
. 2021 Dec;
28(6):e12713.
PMID: 34951057
Porcine islet xenotransplantation is a viable strategy to treat diabetes. Its translation has been limited by the pre-clinical development of a clinically available immunosuppressive regimen. We tested two clinically relevant...
6.
Manook M, Flores W, Schmitz R, Fitch Z, Yoon J, Bae Y, et al.
Front Immunol
. 2021 Jun;
12:660900.
PMID: 34149698
Background: In transplantation, plasmapheresis and IVIg provide the mainstay of treatment directed at reducing or removing circulating donor-specific antibody (DSA), yet both have limitations. We sought to test the efficacy...
7.
Fitch Z, Schmitz R, Kwun J, Hering B, Madsen J, Knechtle S
Transplant Rev (Orlando)
. 2019 Apr;
33(3):115-129.
PMID: 31027947
Research in transplant immunology using non-human primate (NHP) species to evaluate immunologic strategies to prevent rejection and prolong allograft survival has yielded results that have translated successfully into human organ...
8.
Ranney D, Mulvihill M, Yerokun B, Fitch Z, Sun Z, Yang C, et al.
Eur J Cardiothorac Surg
. 2017 May;
52(3):543-551.
PMID: 28498967
Objectives: The purpose of this study was to determine the optimal timing of surgical resection of oesophageal adenocarcinoma following neoadjuvant chemoradiotherapy (nCRT). Methods: nCRT before resection of oesophageal adenocarcinoma yields...